In the FRG the greatest portion of alcoholics only consultate a general practitioner. They often refuse further treatment although being motivated to abstain. The introduction of so-called 'anti-craving' drugs like Acamprosat offers the GPs a new therapeutic strategy. Thus, they will be confronted with the question, who should be treated with these new drugs. That's why, specialists should discuss the indications for an 'anti-craving' medication in time. According to the presented proposal 'anti-craving' drugs should be only prescribed to alcoholics clearly motivated for abstinence as well as therapy. Furthermore, they should have complained about craving in the context of relapses in the past.
|Translated title of the contribution
|Indications for a treatment with 'anti-craving' drugs
|Number of pages
|Published - 1996
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)